Next Issue
June 2021
In the next issue of Pharma Technology Focus, we find out about an orally administered Covid-19 vaccine being developed by Oramed Pharmaceuticals and Premas Biotech, and ask how such a development could impact future vaccine rollout plans. Plus, we take a look at rare disease drug access programmes across the pharma industry to uncover the logistical challenges of getting medications to resource-limited countries.
Elsewhere, we examine the benefits and challenges involved in putting patients closer to the heart of clinical research, and following the US Food and Drug Administration’s decision to reopen a study to determine how drug names influence consumers and healthcare providers, we explore the process of designing and regulating new drug names.
Also, we dig into the importance of academic-industry collaboration to find out how licensing and partnerships be improved, and finally, we round up the key lessons that the pharma supply chain can learn from the Covid-19 pandemic.
EDITORIAL
Editor | Eloise McLennan
Writers | Abi Millar, Chloe Kent, Natalie Healey
Magazine Designer | Marzia Del Gaone
Graphic Designers | Anett Arc, Ashley McPherson, Tyrrell Lowe, Noemi Balint, Maria Gimenez, Filipe Costa, Martina Labaiova
Lead Designer | John Hammond
Publisher | Susanne Hauner
Digital Publishing Director | Duncan West
Advertising
Sales Manager | Nimai Amin
+44 (0) 207 936 6453
Pharma Technology focus is powered by h5mag
read past issues of pharma technology focus HERE
Copyright 2021 NRi Digital, a trading division of Verdict Media Ltd. Registered office John Carpenter House, John Carpenter Street, London, EC4Y 0AN, UK. Company registration number 03171601. All rights reserved. No part of this publication may be reproduced in any form or by any means, electronic, photocopying or otherwise, without prior permission of the publisher and copyright owner. While every effort has been made to ensure the accuracy of this publication, the publisher accepts no responsibility for errors or omissions. The products and services advertised are those of individual authors and are not necessarily endorsed by or connected with the publisher. The opinions expressed in the articles within this publication are those of individual authors and not necessarily those of the publisher.